Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.28	23.55	43.15	70.9	15.17
Cash & Short-Term Investments	4.28	23.55	43.15	70.9	15.17
Cash Growth	-81.83%	-45.42%	-39.15%	367.30%	41.34%
Other Receivables	0.02	0.1	0.02	0.05	0
Receivables	0.02	0.1	0.02	0.05	0
Prepaid Expenses	0.57	2.08	1.63	1.06	0.74
Other Current Assets	0.33	0.55	0.8	0.49	1.28
Total Current Assets	5.19	26.27	45.6	72.5	17.2
Property, Plant & Equipment	0.58	0.8	0.68	0.45	0.69
Other Intangible Assets	11.15	11.15	11.15	11.15	11.15
Total Assets	16.93	38.22	57.42	84.09	29.03
Accounts Payable	2.03	2.5	2.1	1.36	1.13
Accrued Expenses	3.21	4.22	2.61	2.16	1.67
Current Portion of Leases	0.12	0.1	0.12	0.1	0.12
Total Current Liabilities	5.36	6.82	4.82	3.62	2.92
Long-Term Leases	0.36	0.47	0.34	0.06	0.16
Other Long-Term Liabilities	5.23	4.86	0.08	1.41	8.19
Total Liabilities	10.95	12.14	5.23	5.1	11.27
Common Stock	0	0.03	0.03	0.03	0.07
Additional Paid-In Capital	159.38	157.65	153.99	151.73	74.67
Retained Earnings	-153.37	-131.6	-101.84	-72.81	-56.92
Comprehensive Income & Other	-0.04	-0.01	0.01	0.04	-0.06
Shareholders' Equity	5.98	26.07	52.19	78.99	17.76
Total Liabilities & Equity	16.93	38.22	57.42	84.09	29.03
Total Debt	0.48	0.57	0.45	0.16	0.28
Net Cash (Debt)	3.8	22.98	42.69	70.74	14.9
Net Cash Growth	-83.46%	-46.18%	-39.65%	374.92%	43.84%
Net Cash Per Share	1.10	11.63	22.39	39.48	22.69
Filing Date Shares Outstanding	14	2.23	1.91	1.91	1.9
Total Common Shares Outstanding	3.38	2.23	1.91	1.91	0.77
Working Capital	-0.17	19.46	40.78	68.88	14.28
Book Value Per Share	1.77	11.70	27.35	41.46	23.09
Tangible Book Value	-5.17	14.93	41.04	67.85	6.61
Tangible Book Value Per Share	-1.53	6.70	21.51	35.61	8.60
Machinery	1.18	1.17	1.04	0.98	0.96

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q